Delivery Order SPE2DB22D2009-SPE2DB25FM1SP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $1,381.44. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,802.34 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,804.17. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,216.66 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,393.55 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) valued at $1,063.84 with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order was issued on September 15, 2025, with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $1,953.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count). This firm fixed price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,646.19 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on September 17, 2025, with completion scheduled for September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1SPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,378.09 to AmerisourceBergen Drug Corp for the supply of Dextramphetamine-Amphetamine 10 mg capsules (100-count units) with a completion date of September 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the DLA Medical Supply Chain. The company's substantial IDC vehicle enables it to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. This specific delivery order for controlled pharmaceutical products demonstrates the contractor's role in fulfilling essential medical supply needs for federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/26/25 |